dihexa results Peptide Therapy Have you heard of the

Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds

Results With BPC 157 therapy given per-orally, from the very beginning, we revealed quadriceps muscle-to-bone reattachment in rats after surgical detachment of the quadriceps muscle from its attachments, as shown by the functional, ultrasonic, magnetic resonance, biomechanical, macroscopic, and microscopic effects assessments

Synonyms: Body Protection Compound-157, Bepecin

BPC 157 upregulates VEGFR2 expression in rats with hind limb ischemia and endothelial cell culture

When administered under medical supervision, BPC-157 and TB-500 peptide therapy is generally well tolerated

It does not occur independently in nature it is produced through solid-phase peptide synthesis in the laboratory